Baseline correction plays an important role in past and current methodological debates in ERP research (e.g., the Tanner vs. Maess debate in the Journal of Neuroscience Methods), serving as a potential alternative to strong high-pass filtering. However, the very assumptions that underlie traditional baseline also undermine it, implying a reduction in the signal-to-noise ratio. In other words, traditional baseline correction is statistically unnecessary and even undesirable. Including the baseline interval as a predictor in a GLM-based statistical approach allows the data to determine how much baseline correction is needed, including both full traditional and no baseline correction as special cases. This reduces the amount of variance in the residual error term and thus has the potential to increase statistical power.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/psyp.13451 | DOI Listing |
World Neurosurg
December 2024
Spine Unit, Department of Orthopedic Surgery, Rigshospitalet, Copenhagen University Hospital, Inge Lehmanns Vej 6, 2100 Copenhagen, Denmark.
Study Design: Retrospective cohort study OBJECTIVES: The purpose of this study was to compare the 2-year radiological outcome and revision rates in patients with ASD treated with either PSO or PLIF, when PLIF was used to improve sagittal balance.
Methods: In 2016, PLIF was introduced at our institution as an alternative method when restoring lumbar lordosis. We analyzed two cohorts of patients with ASD undergoing either: PSO in 2010-2015 or PLIF in 2016-2020, retrospectively.
Purpose: This study evaluates the efficacy of intravitreal injections (IVI) of faricimab in patients with neovascular age-related macular degeneration (nAMD) and retinal pigment epithelium detachment (RPED) resistant to other anti-VEGF agents.
Material And Methods: The study included 61 patients (61 eyes) with nAMD previously treated with aflibercept and/or brolucizumab IVIs. Three groups were formed: group 1 received aflibercept IVI (32 eyes), group 2 received brolucizumab IVI (14 eyes), and group 3 received aflibercept followed by brolucizumab IVI (15 eyes).
Vestn Oftalmol
December 2024
Novosibirsk State Regional Hospital, Novosibirsk, Russia.
Purpose: This study evaluated the impact of phacoemulsification cataract surgery (PE) on anatomical and functional parameters, as well as the regimen and frequency of anti-VEGF injections in patients with neovascular age-related macular degeneration (nAMD) over a long-term period (up to 3 years).
Material And Methods: The study included 117 patients (117 eyes) diagnosed with nAMD and cataract, graded by LOCS: LOCS I (=56; 47.9%), LOCS II (=57; 48.
Sci Rep
December 2024
School of Human Sciences, University of Western Australia, Crawley, WA, 6009, Australia.
Hearing loss (HL) in mid-life has been suggested as a risk factor for cognitive decline. It is unclear whether this relationship is due to deprivation of auditory input alone, degenerative processes, or a combination. Animal models are useful to investigate underlying neural mechanisms as human studies can be confounded by various factors.
View Article and Find Full Text PDFPediatr Rep
December 2024
Department of Pediatric Neurology, Queen Rania Children's Hospital, Royal Medical Services, Amman 11118, Jordan.
Background/objectives: Routine screening electrocardiograms (ECGs) prior to starting medications for attention-deficit/hyperactivity disorder (ADHD) remain controversial. This real-world study assessed corrected QT (QTc) interval data from pediatric patients who had a baseline ECG performed prior to initiating treatment with ADHD medications and ≥6 months of clinical follow-up.
Methods: A retrospective chart review of children aged 2-18 years diagnosed with ADHD with/without autism spectrum disorder (ASD) at child neurology clinics in Jordan (June 2019 and June 2021) was performed, and children were prescribed with ADHD medications to manage symptoms.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!